首頁 > 市場調查報告書 > 製藥

生物標記

市場調查報告書

商品編碼

1786975

帕金森氏症血液為基礎的生物標記的全球市場，規模，佔有率，產業分析報告:各生物標記類型，各用途，各技術平台，各終端用戶，各地區 - 市場預測(2025年～2034年)

Blood-Based Biomarker for Parkinson's Disease Market Size, Share, Industry Analysis Report By Biomarker Type, By Application, By Technology Platform, By End User, By Region - Market Forecast, 2025-2034

出版日期: 2025年07月01日 | 出版商:

Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

根據 Polaris Market Research 的最新研究，預計到 2034 年，全球帕金森氏症血液生物標記市場規模將達到 27.1191 億美元。本研究報告深入分析了當前的市場動態，並分析了未來的市場成長。

帕金森氏症血液生物標記是可在血液中檢測到的分子指標，可用於了解疾病的存在、進展和治療反應。隨著醫療保健系統將重點從對症治療轉向及時幹預和預防，並更加重視早期檢測，這些生物標記正日益受到關注。對微創診斷方法日益增長的需求，促使臨床研究人員和診斷開發人員開發能夠在早期識別帕金森氏症的血液檢測方法。這一趨勢也得到了臨床醫生日益認識到生物標記在區分帕金森氏症與類似神經退化性疾病方面的效用的支持。

帕金森氏症血液生物標記市場正受到多組學技術整合的影響，旨在增強生物標記的發現和驗證。基因組學、蛋白質組學和代謝組學的進展使我們能夠在分子層面上更全面地了解帕金森氏症，從而能夠鑑定出特異性和敏感性更高的新型血液生物標記。這些技術與臨床研究的融合加快了生物標記的開發速度，並擴大了其在臨床試驗和個人化醫療中的應用。因此，市場正快速朝向精準驅動、數據驅動的診斷解決方案發展。

帕金森氏症血液生物標記市場亮點

按應用劃分，診斷生物標記領域預計將在2024年以2.041億美元的收入引領市場。

按生物標記類型劃分，NFL生物標記領域預計在預測期內將錄得最高的複合年增長率，達到19.00%，這得益於其作為多種神經系統疾病中神經退化性疾病的敏感指標的成熟應用。

得益於先進的醫療體係以及主要生物標記開發商和研究機構的集中分佈，預計北美將在2024年佔全球市場佔有率的45.00%。

受生物醫學研究投資、診斷服務增強以及疾病宣傳活動不斷加強的推動，預計亞太市場在 2025 年至 2034 年期間的複合年增長率將達到 20.50%。

帕金森氏症血液生物標記市場的全球領先公司包括雅培實驗室、Adx Neurosciences、Alamar Biosciences、betaSENSE、羅氏公司、默克集團、Proteome Sciences、凱傑公司、Quanterix Corporation 和賽默飛世爾科技公司。

市場概述
帕金森氏症血液為基礎的生物標記市場力學
- 促進因素和機會
  - 巴金森病患病率不斷上升
  - 生物標記發現與驗證的進展
- 限制因素與挑戰
  - 缺乏標準化和臨床驗證
PESTEL分析
帕金森氏症血液為基礎的生物標記市場趨勢
價值鏈分析

第5章帕金森氏症血液為基礎的生物標記的全球市場:各生物廠商類型

主要調查結果
簡介
α-突觸核蛋白(α-Syn)
神經長絲輕鎖鏈(NfL)
發炎標記
代謝生物標記
其他

第6章帕金森氏症血液為基礎的生物標記的全球市場:各用途

主要調查結果
簡介
診斷生物標記
預後生物標記
生物標記的監測
治療反應生物標記
其他

第7章帕金森氏症血液為基礎的生物標記的全球市場:各技術平台

主要調查結果
簡介
α-突觸核蛋白種子擴增試驗 (aSyn-SAA)
基於 ELISA 的試驗
免疫試驗
質譜光譜法
其他

第8章帕金森氏症血液為基礎的生物標記的全球市場:各終端用戶

主要調查結果
簡介
醫院和診療所
診斷檢驗室
研究機關
製藥公司

第9章帕金森氏症血液為基礎的生物標記的全球市場:各地區

主要調查結果
簡介
- 帕金森氏症血液為基礎的生物標記市場評估:各地區，2020年～2034年
北美
- 北美:各生物廠商類型，2020～2034年
- 北美:各用途，2020～2034年
- 北美:各技術平台，2020～2034年
- 北美:各終端用戶，2020～2034年
- 美國
- 加拿大
歐洲
- 歐洲:各生物廠商類型，2020～2034年
- 歐洲:各用途，2020～2034年
- 歐洲:各技術平台，2020～2034年
- 歐洲:各終端用戶，2020～2034年
- 英國
- 法國
- 德國
- 義大利
- 西班牙
- 荷蘭
- 俄羅斯
- 其他歐洲
亞太地區
- 亞太地區:各生物廠商類型，2020～2034年
- 亞太地區:各用途，2020～2034年
- 亞太地區:各技術平台，2020～2034年
- 亞太地區:各終端用戶，2020～2034年
- 中國
- 印度
- 馬來西亞
- 日本
- 印尼
- 韓國
- 澳洲
- 其他亞太地區
中東·非洲
- 中東·非洲:各生物廠商類型，2020～2034年
- 中東·非洲:各用途，2020～2034年
- 中東·非洲:各技術平台，2020～2034年
- 中東·非洲:各終端用戶，2020～2034年
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 南非
- 其他中東·aafurika
南美
- 南美:各生物廠商類型，2020～2034年
- 南美:各用途，2020～2034年
- 南美:各技術平台，2020～2034年
- 南美:各終端用戶，2020～2034年
- 墨西哥
- 巴西
- 阿根廷
- 其他南美國家

第10章競爭情形

事業擴大·收購分析
- 事業擴大
- 收購
聯盟/合作/協定/公開

第11章企業簡介

Abbott Laboratories
Adx Neurosciences
Alamar Biosciences
betaSENSE
F. Hoffmann-La Roche Ltd
Merck KGaA
Merck KGaA
QIAGEN N.V.
Quanterix Corporation
Thermo Fisher Scientific Inc.

簡介目錄圖表

Product Code: PM5992

The blood-based biomarker for Parkinson's disease market size is expected to reach USD 2,711.91 million by 2034, according to a new study by Polaris Market Research. The report "Blood-Based Biomarker for Parkinson's Disease Market Share, Size, Trends, Industry Analysis Report By Biomarker Type [Alpha-Synuclein (a-syn), Neurofilament Light Chain (Nfl)], By Application, By Technology Platform, By End User, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Blood-based biomarkers for Parkinson's disease are molecular indicators detectable in blood that provide insights into the presence, progression, and therapeutic response of the disease. These biomarkers are gaining prominence as healthcare systems focus on early-stage detection, aiming to shift from symptomatic treatment to timely intervention and prevention. The growing demand for minimally invasive diagnostic approaches is encouraging clinical researchers and diagnostic developers to advance blood-based assays capable of identifying Parkinson's at its earliest stages. This trend is also being supported by rising awareness among clinicians regarding the utility of biomarkers in differentiating Parkinson's from similar neurodegenerative disorders.

The blood-based biomarker for Parkinson's disease market is shaped by the integration of multi-omics technologies to enhance biomarker discovery and validation. Advances in genomics, proteomics, and metabolomics are enabling a more comprehensive understanding of Parkinson's disease at the molecular level, leading to the identification of novel blood-based biomarkers with improved specificity and sensitivity. This convergence of technology and clinical research is accelerating the pace of biomarker development and also expanding their applicability in clinical trials and personalized medicine. As a result, the market is evolving rapidly toward precision-driven, data-enabled diagnostic solutions.

Blood-Based Biomarker for Parkinson's Disease Market Report Highlights

In terms of application, the diagnostic biomarkers segment led revenue generation with USD 204.10 million in 2024, due to their critical role in detecting Parkinson's during early/prodromal stages when intervention is most impactful.

Based on biomarker type, the NfL biomarker segment is projected to register the highest CAGR of 19.00% during the forecast period, owing to its established utility as a sensitive neurodegeneration indicator across multiple neurological disorders.

North America held a 45.00% global share in 2024, benefiting from its advanced healthcare systems and the concentrated presence of leading biomarker developers and research institutions.

The market in Asia Pacific is expected to register a CAGR of 20.50% from 2025 to 2034, driven by investments in biomedical research, enhancements in diagnostic services, and rising awareness campaigns for diseases.

A few global key players in the blood-based biomarker for Parkinson's disease market include Abbott Laboratories, Adx Neurosciences, Alamar Biosciences, betaSENSE, F. Hoffmann-La Roche Ltd, Merck KGaA, Proteome Sciences, QIAGEN N.V., Quanterix Corporation, and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the blood-based biomarker for Parkinson's disease market report on the basis of biomarker type, application, technology platform, end user, and region:

By Biomarker Type Outlook (Revenue, USD Million, 2020-2034)

Alpha-Synuclein (a-Syn)

Neurofilament Light Chain (NfL)

Inflammatory Markers

Metabolic Biomarkers

Others

By Application Outlook (Revenue, USD Million, 2020-2034)

Diagnostic Biomarkers

Prognostic Biomarkers

Monitoring Biomarkers

Therapeutic Response Biomarkers

Others

By Technology Platform Outlook (Revenue, USD Million, 2020-2034)

Alpha-Synuclein Seeding Amplification Assay (aSyn-SAA)

ELISA-Based Assays

Immunoassays

Mass Spectrometry

Others

By End User Outlook (Revenue, USD Million, 2020-2034)

Hospitals and Clinics

Diagnostic Laboratories

Research Institutes

Pharmaceutical Companies

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Blood-Based Biomarker for Parkinson's Disease Market Insights

4.1. Blood-Based Biomarker for Parkinson's Disease Market - Market Snapshot
4.2. Blood-Based Biomarker for Parkinson's Disease Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Parkinson's Disease
  - 4.2.1.2. Advancements in Biomarker Discovery and Validation
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Lack of Standardization and Clinical Validation
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Blood-Based Biomarker for Parkinson's Disease Market Trends
4.6. Value Chain Analysis

5. Global Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
5.3. Alpha-Synuclein (a-Syn)
- 5.3.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Alpha-Synuclein (a-Syn), by Region, 2020-2034 (USD Billion)
5.4. Neurofilament Light Chain (NfL)
- 5.4.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Neurofilament Light Chain (NfL), by Region, 2020-2034 (USD Billion)
5.5. Inflammatory Markers
- 5.5.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Inflammatory Markers, by Region, 2020-2034 (USD Billion)
5.6. Metabolic Biomarkers
- 5.6.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Metabolic Biomarkers, by Region, 2020-2034 (USD Billion)
5.7. Others
- 5.7.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Blood-Based Biomarker for Parkinson's Disease Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
6.3. Diagnostic Biomarkers
- 6.3.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Diagnostic Biomarkers, by Region, 2020-2034 (USD Billion)
6.4. Prognostic Biomarkers
- 6.4.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Prognostic Biomarkers, by Region, 2020-2034 (USD Billion)
6.5. Monitoring Biomarkers
- 6.5.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Monitoring Biomarkers, by Region, 2020-2034 (USD Billion)
6.6. Therapeutic Response Biomarkers
- 6.6.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Therapeutic Response Biomarkers, by Region, 2020-2034 (USD Billion)
6.7. Others
- 6.7.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
7.3. Alpha-Synuclein Seeding Amplification Assay (aSyn-SAA)
- 7.3.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Alpha-Synuclein Seeding Amplification Assay (aSyn-SAA), by Region, 2020-2034 (USD Billion)
7.4. ELISA-Based Assays
- 7.4.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by ELISA-Based Assays, by Region, 2020-2034 (USD Billion)
7.5. Immunoassays
- 7.5.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Immunoassays, by Region, 2020-2034 (USD Billion)
7.6. Mass Spectrometry
- 7.6.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Mass Spectrometry, by Region, 2020-2034 (USD Billion)
7.7. Others
- 7.7.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Blood-Based Biomarker for Parkinson's Disease Market, by End User

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
8.3. Hospitals and Clinics
- 8.3.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Hospitals and Clinics, by Region, 2020-2034 (USD Billion)
8.4. Diagnostic Laboratories
- 8.4.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Billion)
8.5. Research Institutes
- 8.5.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Research Institutes, by Region, 2020-2034 (USD Billion)
8.6. Pharmaceutical Companies
- 8.6.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)

9. Global Blood-Based Biomarker for Parkinson's Disease Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Blood-Based Biomarker for Parkinson's Disease Market Assessment, By Geography, 2020-2034 (USD Billion)
9.3. Blood-Based Biomarker for Parkinson's Disease Market - North America
- 9.3.1. North America: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
- 9.3.2. North America: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
- 9.3.3. North America: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
- 9.3.4. North America: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.3.5. Blood-Based Biomarker for Parkinson's Disease Market - US
  - 9.3.5.1. US: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.3.5.2. US: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.3.5.3. US: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.3.5.4. US: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.3.6. Blood-Based Biomarker for Parkinson's Disease Market - Canada
  - 9.3.6.1. Canada: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.3.6.2. Canada: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.3.6.3. Canada: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.3.6.4. Canada: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
9.4. Blood-Based Biomarker for Parkinson's Disease Market - Europe
- 9.4.1. Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
- 9.4.2. Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
- 9.4.3. Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
- 9.4.4. Europe: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.4.5. Blood-Based Biomarker for Parkinson's Disease Market - UK
  - 9.4.5.1. UK: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.4.5.2. UK: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.4.5.3. UK: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.4.5.4. UK: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.4.6. Blood-Based Biomarker for Parkinson's Disease Market - France
  - 9.4.6.1. France: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.4.6.2. France: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.4.6.3. France: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.4.6.4. France: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.4.7. Blood-Based Biomarker for Parkinson's Disease Market - Germany
  - 9.4.7.1. Germany: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.4.7.2. Germany: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.4.7.3. Germany: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.4.7.4. Germany: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.4.8. Blood-Based Biomarker for Parkinson's Disease Market - Italy
  - 9.4.8.1. Italy: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.4.8.2. Italy: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.4.8.3. Italy: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.4.8.4. Italy: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.4.9. Blood-Based Biomarker for Parkinson's Disease Market - Spain
  - 9.4.9.1. Spain: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.4.9.2. Spain: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.4.9.3. Spain: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.4.9.4. Spain: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.4.10. Blood-Based Biomarker for Parkinson's Disease Market - Netherlands
  - 9.4.10.1. Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.4.10.2. Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.4.10.3. Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.4.10.4. Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.4.11. Blood-Based Biomarker for Parkinson's Disease Market - Russia
  - 9.4.11.1. Russia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.4.11.2. Russia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.4.11.3. Russia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.4.11.4. Russia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.4.12. Blood-Based Biomarker for Parkinson's Disease Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.4.12.2. Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.4.12.3. Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.4.12.4. Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
9.5. Blood-Based Biomarker for Parkinson's Disease Market - Asia Pacific
- 9.5.1. Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.5.5. Blood-Based Biomarker for Parkinson's Disease Market - China
  - 9.5.5.1. China: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.5.5.2. China: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.5.5.3. China: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.5.5.4. China: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.5.6. Blood-Based Biomarker for Parkinson's Disease Market - India
  - 9.5.6.1. India: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.5.6.2. India: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.5.6.3. India: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.5.6.4. India: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.5.7. Blood-Based Biomarker for Parkinson's Disease Market - Malaysia
  - 9.5.7.1. Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.5.7.2. Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.5.7.3. Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.5.7.4. Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.5.8. Blood-Based Biomarker for Parkinson's Disease Market - Japan
  - 9.5.8.1. Japan: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.5.8.2. Japan: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.5.8.3. Japan: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.5.8.4. Japan: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.5.9. Blood-Based Biomarker for Parkinson's Disease Market - Indonesia
  - 9.5.9.1. Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.5.9.2. Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.5.9.3. Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.5.9.4. Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.5.10. Blood-Based Biomarker for Parkinson's Disease Market - South Korea
  - 9.5.10.1. South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.5.10.2. South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.5.10.3. South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.5.10.4. South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.5.11. Blood-Based Biomarker for Parkinson's Disease Market - Australia
  - 9.5.11.1. Australia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.5.11.2. Australia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.5.11.3. Australia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.5.11.4. Australia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.5.12. Blood-Based Biomarker for Parkinson's Disease Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.5.12.2. Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.5.12.3. Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.5.12.4. Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
9.6. Blood-Based Biomarker for Parkinson's Disease Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.6.5. Blood-Based Biomarker for Parkinson's Disease Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.6.6. Blood-Based Biomarker for Parkinson's Disease Market - UAE
  - 9.6.6.1. UAE: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.6.6.2. UAE: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.6.6.3. UAE: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.6.6.4. UAE: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.6.7. Blood-Based Biomarker for Parkinson's Disease Market - Israel
  - 9.6.7.1. Israel: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.6.7.2. Israel: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.6.7.3. Israel: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.6.7.4. Israel: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.6.8. Blood-Based Biomarker for Parkinson's Disease Market - South Africa
  - 9.6.8.1. South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.6.8.2. South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.6.8.3. South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.6.8.4. South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.6.9. Blood-Based Biomarker for Parkinson's Disease Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.6.9.2. Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.6.9.3. Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.6.9.4. Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
9.7. Blood-Based Biomarker for Parkinson's Disease Market - Latin America
- 9.7.1. Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.7.5. Blood-Based Biomarker for Parkinson's Disease Market - Mexico
  - 9.7.5.1. Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.7.5.2. Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.7.5.3. Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.7.5.4. Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.7.6. Blood-Based Biomarker for Parkinson's Disease Market - Brazil
  - 9.7.6.1. Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.7.6.2. Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.7.6.3. Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.7.6.4. Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.7.7. Blood-Based Biomarker for Parkinson's Disease Market - Argentina
  - 9.7.7.1. Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.7.7.2. Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.7.7.3. Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.7.7.4. Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.7.8. Blood-Based Biomarker for Parkinson's Disease Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.7.8.2. Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.7.8.3. Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.7.8.4. Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Abbott Laboratories
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Adx Neurosciences
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Alamar Biosciences
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. betaSENSE
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. F. Hoffmann-La Roche Ltd
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Merck KGaA
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Merck KGaA
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. QIAGEN N.V.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Quanterix Corporation
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Thermo Fisher Scientific Inc.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development

簡介目錄圖表

List of Tables:

Table 1 Global Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 2 Global Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 3 Global Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 4 Global Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 5 North America: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 6 North America: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 7 North America: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 8 North America: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 9 US: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 10 US: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 11 US: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 12 US: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 13 Canada: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 14 Canada: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 15 Canada: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 16 Canada: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 17 Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 18 Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 19 Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 20 Europe: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 21 UK: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 22 UK: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 23 UK: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 24 UK: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 25 France: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 26 France: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 27 France: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 28 France: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 29 Germany: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 30 Germany: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 31 Germany: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 32 Germany: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 33 Italy: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 34 Italy: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 35 Italy: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 36 Italy: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 37 Spain: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 38 Spain: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 39 Spain: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 40 Spain: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 41 Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 42 Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 43 Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 44 Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 45 Russia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 46 Russia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 47 Russia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 48 Russia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 49 Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 50 Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 51 Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 52 Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 53 Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 54 Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 55 Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 56 Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 57 China: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 58 China: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 59 China: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 60 China: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 61 India: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 62 India: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 63 India: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 64 India: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 65 Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 66 Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 67 Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 68 Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 69 Japan: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 70 Japan: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 71 Japan: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 72 Japan: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 73 Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 74 Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 75 Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 76 Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 77 South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 78 South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 79 South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 80 South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 81 Australia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 82 Australia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 83 Australia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 84 Australia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 85 Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 86 Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 87 Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 88 Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 89 Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 90 Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 91 Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 92 Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 93 Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 94 Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 95 Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 96 Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 97 UAE: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 98 UAE: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 99 UAE: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 100 UAE: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 101 Israel: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 102 Israel: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 103 Israel: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 104 Israel: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 105 South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 106 South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 107 South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 108 South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 109 Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 110 Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 111 Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 112 Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 113 Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 114 Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 115 Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 116 Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 117 Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 118 Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 119 Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 120 Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 121 Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 122 Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 123 Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 124 Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 125 Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 126 Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 127 Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 128 Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 129 Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 130 Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 131 Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 132 Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Blood-Based Biomarker for Parkinson's Disease Market, 2020-2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Biomaker Type
Figure 7. Global Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2024 & 2034 (USD Billion)
Figure 8. Market by Application
Figure 9. Global Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2024 & 2034 (USD Billion)
Figure 10. Market by Technology Platform
Figure 11. Global Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2024 & 2034 (USD Billion)
Figure 12. Market by End User
Figure 13. Global Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2024 & 2034 (USD Billion)
Figure 14. Global Blood-Based Biomarker for Parkinson's Disease Market Assessment, By Geography, 2020-2034 (USD Billion)
Figure 15. Strategic Analysis - Global Blood-Based Biomarker for Parkinson's Disease Market